Antioxidants, Free Radical Stress and Diabetes

  • Shanti S. Rastogi
  • Ram B. Singh
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 498)


The DCCT, the UKPD and the DAGMI studies have demonstrated the role of hypoglycemic agents such as human insulin and metformin in the management of diabetes and its vascular complications and in decreasing mortality. However, many subjects died in the intervention groups of these studies indicating that beyond tight control of glucose, further intervention is necessary to reduce clinical events and progression of vascular disease. Increased consumption of refined sugar, total and saturated fat and linoleic acid rich oils and lower intake of n-3 fatty acids and antioxidant vitamins and coenzyme Q10 in the diet in association with smoking and sedentaryness have been suggested to be important risk factors of diabetes and cardiovascular disease (CVD)1–3


Antioxidant Vitamin Lipid Soluble Antioxidant South Asian Immigrant Free Radical Stress Acute Coronary Artery Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    WHO Study Group. Diet, Nutrition and Prevention of Chronic Diseases. WHO, Geneva, 1990Google Scholar
  2. 2.
    Indian Consensus Group. Indian Consensus for Prevention of Hypertension and Coronary Artery Disease. J Nutr Environ Med, 1996, 6:309–318CrossRefGoogle Scholar
  3. 3.
    Singh RB, Antioxidants, Free radical stress and coronary artery disease. J Intern Med India 1996, 7:23–24Google Scholar
  4. 4.
    Malmberg K, for DEGAMI Study Group. Prospective randomized study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ 1997, 394:1512–15CrossRefGoogle Scholar
  5. 5.
    Packer L. The role of antioxidative treatment in diabetes mellitus. Diabetologia 1993, 36:1212–1213PubMedCrossRefGoogle Scholar
  6. 6.
    Wolff SP. Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stress in the etiology of diabetes mellitus and complications. Br Med Bull 1993, 49:642–652PubMedGoogle Scholar
  7. 7.
    Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991, 40:405–412PubMedCrossRefGoogle Scholar
  8. 8.
    Cadnas E, Packer L. Handbook of Antioxidants. Marcel Dekker, Inc. New York, 1996, P. 157–203Google Scholar
  9. 9.
    Singh RB, Beegon R, Rastogi V, Rastogi SS, Madhu SV, Clinical characteristics and hypertension among known patients of noninsulin dependent diabetes mellitus in north and south Indians. J Diab Asso India 1996, 36:45–50Google Scholar
  10. 10.
    Singh RB, Rastogi V, Aslam M, Niaz MA, Rastogi SS. Diabetes mellitus and its determinants and risk ofcoronary artery disease in rural and urban populations of north India. Int J Cardio, 1998, 66:65–72CrossRefGoogle Scholar
  11. 11.
    Indian Consensus Group for Prevention of Diabetes. Diet and lifestyle guidelines and desirable levels of risk factors for prevention of diabetes and its vascular complications in Indians: A scientific statement of the International College of Nutrition. J Cardivas Risk 1997, 4:201–208CrossRefGoogle Scholar
  12. 12.
    Singh RB, Niaz MA, Gupta S, Rastogi SS etal. Diet, antioxidant vitamins, oxidative stress and risk of coronary disease. The Peerzada Prospective study. Acta Cardio 1994, 49:463–467Google Scholar
  13. 13.
    Singh RB, Ghosh S, Niaz MA etal. Dietary intake, plasma levels of antioxidant vitamins and oxidative stress in relation to coronary artery disease in elderly subjects. Am J Cardio, 1995, 76:1233–1238CrossRefGoogle Scholar
  14. 14.
    Salonen JT, Nyyssonen K, Tuomainen TP, Maenpaa P, Korpela H, Kaplan GA, Lynch J, Helmrich SP, Salonen R. Increased risk of non-insulin dependent diabetes mellitus at low plasma vitamin E concentration: a four year follow up study in men. BMJ 1996, 311:1124–1127Google Scholar
  15. 15.
    Singh RB, Niaz MA, Sharma JP, Kumar R, Bishnoi I, Beegom R. Plasma levels of antioxidant vitamins and oxidative stress in patients with acute myocardial infarction. Acta Cardio 1994, 49:441–452Google Scholar
  16. 16.
    Singh RB, Niaz MA, Ghosh S etal. Dietary intake and plasma levels of antioxidant vitamins in health and disease: a hospital based case control study. J Nutr Environ Med, 1995, 5:235–242CrossRefGoogle Scholar
  17. 17.
    Bambolker S. Sainani GS. Evaluation of oxidative stress in diabetics with or without vascular complications. J Asso Phys India 1995, 43:10–12Google Scholar
  18. 18.
    Malaisse WJ, Alloxan toxicity of the pancreatic beta cell: a new hypothesis. Biochem Pharmac 1982, 22:3527–2524CrossRefGoogle Scholar
  19. 19.
    Mendola J, Wright Jr JR, Lacy P: Oxygen Free radical scavengers and immune destruction of murine islets in allograft rejection and multiple low dose streptozotocin induced insulitis. Diabetes 1989, 38:379–385PubMedCrossRefGoogle Scholar
  20. 20.
    Flechner I, Maruta X, Burkart V, Kawai K, Kolb H, Kiesel U. Effects of radical scavengers on the development of experimental diabetes. Diabetes Res 1990, 13:6773Google Scholar
  21. 21.
    Mateo MCM, Bustamante JB, Cantalapiedra MAG. Serum, zinc, copper and insulin in diabetes mellitus, Biomed 1978, 29:56–58Google Scholar
  22. 22.
    Noto R, Alicata R, Sfolgliano L. A study of cupremia in a group of elderly diabetics. Acta Diabetol Latina 1983, 20:81–85Google Scholar
  23. 23.
    Singh RB, Niaz MA, Rastogi SS, Singh U, Agarwal P. Dietary and serum levels of antioxidant minerals in patients with acute myocardial infarction. Trace Elem Electrolytes 1995, 12:148–152Google Scholar
  24. 24.
    Jiang ZY, Quong LZ, Eaton JW, Hunt JV, Koppenol WH, Wolf SP, Spirohydantoin inhibitors of aldose reductase inhibit iron and copper catalysed ascorbic oxidation in vitro Biochem Pharmaco 1991, 42:1273–1278CrossRefGoogle Scholar
  25. 25.
    Kinlaw WB, Levine AS, Morley JE, Silvis SE, McClain CJ. Abmnormal zinc metabolism in type II diabetes mellitus. Am J Med 1983 75: 273–277PubMedCrossRefGoogle Scholar
  26. 26.
    Ohrvall M, Tengblad S, Vessby B. Lower tocopherol serum levels in subjects with abdominal obesity. J Intern Med 1993, 234:53–60PubMedCrossRefGoogle Scholar
  27. 27.
    Pipek R, Dankner G, Ben-Amotz A, Aviram M, Levy Y. Increased plasma oxidizability in subjects with severe obesity. J Nutr Environ Med 1996, 6:267–272CrossRefGoogle Scholar
  28. 28.
    Karlsson J, Diamant B, Edlund PO, Lund B, Folkers K, Theorell H. Plasma ubiquinone, alpha _ tocopherol, and cholesterol in man. Int J Vit Nutr Res 1992, 62:160–164Google Scholar
  29. 29.
    Karlsson J, Semb B. Muscle obiquinone and plasma antioxidants in effort angina. J Nutr environ Med 1996, 6:255–266CrossRefGoogle Scholar
  30. 30.
    Hofman-Bang C, Rehnqvist N, Swedberg K, Astrom H. Coenzyme Q10 as an adjunctive in treatment of congestive heart failure. J Am Coll Cardio 1992, 19 (Suppl):774–776Google Scholar
  31. 31.
    Kamikawa T. Effects of coenzyme Q10 on exercise tolerance in chronic stable angina pectoris. Am J Cariol, 1985, 56:247–251CrossRefGoogle Scholar
  32. 32.
    Chelo M, Protection of coenzyme Q10 from myocardial reperfusion injury during coronary artery bypass grafting. Ann Thiorac Surg 1994, 58:1427–1482CrossRefGoogle Scholar
  33. 33.
    Kishi T. Bioenergetics in clinical medicine, XI, Studies on coenzyme Q and diabetes mellitus. J Med 1976, 7:307–312PubMedGoogle Scholar
  34. 34.
    Shigeta Y, Izumik, Abe H. Effect of coenzyme Q7 treatment on blood sugar and ketone bodies of diabetics. J Vitaminol 1966, 12:293–297CrossRefGoogle Scholar
  35. 35.
    Paolisso G, D’Amore A, Giugliano D, Ceriell A, Varrichio M, D’Onofrio F. Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin dependent diabetic patients. Am J Clin Nutr 1993, 57:650–656PubMedGoogle Scholar
  36. 36.
    Caballero B. Vitamin E improves the action of insulin. Nutr Rev 1993, 51:339–340PubMedCrossRefGoogle Scholar
  37. 37.
    Packer L. The role of antioxidative treatment in diabetes mellitus workshop report. Diabetologia 1993, 36:1112–1114CrossRefGoogle Scholar
  38. 38.
    Sadikot SM, Raheja, BS. Vitamin E supplementation and oxidant stress in diabetes. J Diab Assoc India 1991, 31: 68–70Google Scholar
  39. 39.
    Raheja BS, Sadikot SM. Vitamin C supplementation decreases oxidant stress and free radical damage in diabetes. J Diab Assoc India 1991, 31:79–81Google Scholar
  40. 40.
    Singh RB, Niaz MA, Agarwal P, Beegom R, Rastogi SS. Effect of antioxidant rich foods on plasma ascorbic acid, cardiac enzyme and lipid peroxide levels in patients hospitalized with acute myocardial infarction. J Am Diet Assoc 1995, 95:775–580PubMedCrossRefGoogle Scholar
  41. 41.
    Wilkinson P, Sayer J, Lajik etal. Comparison of case fatality in south Asians and white patients after acute myocardial infarction: observational study. BMJ, 1996, 312:1330–1333PubMedCrossRefGoogle Scholar
  42. 42.
    Shaukat N, Lear J, Lowy A. etal. First myocardial infarction in patients at Indian subcontinent and European origin: comparison of risk factors, management and long term outcome. BMJ 1997, 314:639–642PubMedCrossRefGoogle Scholar
  43. 43.
    Singh RB, Wander GS, Rastogi A. etal. Randomized, double blind, placebo-controlled trial of coenzyme Q10 in patients with acute myocardial infarction. Cardiovas Drug Thcr 1998, 12:347–353Google Scholar
  44. 44.
    Singh RB, Niaz MA. Serum concentration of lipoprotein(a) decreases on treatment with hydrosoluble coenzyme Q10 in patients with coronary artery disease: discovery of a new role. Int. J Cardio 1999, 68:23–29Google Scholar
  45. 45.
    Singh RB, Niaz MA, Rastogi SS, Shukla PK, Thakur AS. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. J Human Hyper 1999, 13:203–208CrossRefGoogle Scholar
  46. 46.
    Singh RB, Shinde SN, Chopra RK, Niaz MA, Thakur AS, Onouchi Z. Effect of coenzyme Q10 on experimental atherosclerosis and chemical composition and quality of atheroma in rabbits. Atherosclerosis, 2000, 148:275–282PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Shanti S. Rastogi
    • 1
  • Ram B. Singh
    • 2
  1. 1.Endocrine Point and Centre for Diabetes and NutritionDelhiIndia
  2. 2.Medical Hospital and Research CentreMoradabadIndia

Personalised recommendations